Spots Global Cancer Trial Database for biodistribution
Every month we try and update this database with for biodistribution cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study) | NCT04726033 | Metastatic Pros... | 64Cu-DOTA-TLX59... | - | Telix Pharmaceuticals (Innovations) Pty Limited | |
Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors | NCT02345174 | Cancer Neoplasms | GSK2849330 89Zr-GSK2849330 | 18 Years - | GlaxoSmithKline | |
Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | NCT02139371 | Breast Cancer Prostate Cancer Urinary Bladder... | Injection of 64... | 18 Years - 80 Years | Rigshospitalet, Denmark | |
Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton | NCT00748046 | Prostate Cancer Metastases Pharmacokinetic... | Radium-223 chlo... | 18 Years - | Bayer | |
Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors | NCT00925275 | Solid Tumors | I-131-CLR1404 | 18 Years - | Cellectar, Inc | |
64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study) | NCT04726033 | Metastatic Pros... | 64Cu-DOTA-TLX59... | - | Telix Pharmaceuticals (Innovations) Pty Limited | |
Amatuximab for High Mesothelin Cancers | NCT01413451 | Carcinoma, Panc... Mesothelioma Ovarian Neoplas... Carcinoma, Non-... | Amatuximab (MOR... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) |